Literature DB >> 22009428

Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.

Hiroyasu Fujiwara1, Shigeki Sekine, Hiroaki Onaya, Kazuaki Shimada, Rintaro Mikata, Yasuaki Arai.   

Abstract

We report a case of focal nodular hyperplasia in a patient for whom gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and histological analysis results were available. Dynamic contrast-enhanced computed tomography showed a well-defined hypervascular lesion 14 mm in diameter with no visible central scars. Gd-EOB-DTPA-enhanced MRI demonstrated strong peripheral enhancement of the lesion during the hepatobiliary phase, resulting in ring-like enhancement. The pathology examination revealed that the lesion was focal nodular hyperplasia (FNH). Immunohistochemistry showed positive expression of OATP8 in the hepatocytes in the peripheral areas of the lesion, whereas expression of OATP8 was lacking in hepatocytes surrounding the central radiating scar. Ring-like enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI may be an important clue for the diagnosis of small FNH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009428     DOI: 10.1007/s11604-011-0624-4

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  10 in total

1.  CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation.

Authors:  K J Mortelé; M Praet; H Van Vlierberghe; M Kunnen; P R Ros
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

2.  Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.

Authors:  Takahiro Tsuboyama; Hiromitsu Onishi; Tonsok Kim; Hirofumi Akita; Masatoshi Hori; Mitsuaki Tatsumi; Atsushi Nakamoto; Hiroaki Nagano; Nariaki Matsuura; Kenichi Wakasa; Kaname Tomoda
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.

Authors:  Adib R Karam; Sridhar Shankar; Padmaja Surapaneni; Young H Kim; Sarwat Hussain
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

4.  Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations.

Authors:  Alexander Huppertz; Sibylle Haraida; Armin Kraus; Christoph J Zech; Juergen Scheidler; Josy Breuer; Thomas K Helmberger; Maximilian F Reiser
Journal:  Radiology       Date:  2004-12-10       Impact factor: 11.105

5.  Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

Authors:  L Grazioli; G Morana; M P Federle; G Brancatelli; M Testoni; M A Kirchin; K Menni; L Olivetti; N Nicoli; C Procacci
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

6.  Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.

Authors:  G M Kacl; K D Hagspiel; B Marincek
Journal:  Abdom Imaging       Date:  1997 May-Jun

7.  Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.

Authors:  Ahmed Ba-Ssalamah; Wolfgang Schima; Maria T Schmook; Ken F Linnau; Nadja Schibany; Thomas Helbich; Peter Reimer; Friedrich Laengle; Friedrich Wrba; Amir Kurtaran; Mark Ryan; Frederick A Mann
Journal:  AJR Am J Roentgenol       Date:  2002-12       Impact factor: 3.959

8.  Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver.

Authors:  Sara Vander Borght; Louis Libbrecht; Hans Blokzijl; Klaas Nico Faber; Han Moshage; Raymond Aerts; Werner Van Steenbergen; Peter L Jansen; Valeer J Desmet; Tania A Roskams
Journal:  J Pathol       Date:  2005-12       Impact factor: 7.996

9.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

10.  Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors:  Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-07       Impact factor: 6.016

  10 in total
  13 in total

1.  Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.

Authors:  Christian Grieser; Ingo G Steffen; Incken-Birthe Kramme; Hendrik Bläker; Ergin Kilic; Carmen Maria Perez Fernandez; Daniel Seehofer; Eckart Schott; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2014-06       Impact factor: 5.315

2.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

Review 3.  Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.

Authors:  Cathryn L Hui; Marcela Mautone
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

4.  Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.

Authors:  Adele Taibbi; Giuseppe Brancatelli; Domenica Matranga; Massimo Midiri; Roberto Lagalla; Tommaso Vincenzo Bartolotta
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

5.  OATP1B3 Expression in Hepatocellular Carcinoma Correlates with Intralesional Gd-EOB-DTPA Uptake and Signal Intensity on Gd-EOB-DTPA-Enhanced MRI.

Authors:  Xiaojiao Zhou; Liling Long; Zhiqing Mo; Yajuan Li
Journal:  Cancer Manag Res       Date:  2021-02-09       Impact factor: 3.989

6.  Liver-specific contrast agents.

Authors:  Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

7.  Hepatic adenomatosis in liver cirrhosis.

Authors:  Sonja Gordic; Swan N Thung; Sasan Roayaie; Mathilde Wagner; Bachir Taouli
Journal:  Eur J Radiol Open       Date:  2017-09-09

8.  Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.

Authors:  Morgane Van Wettere; Luisa Paulatto; Lucas Raynaud; Onorina Bruno; Audrey Payancé; Aurélie Plessier; Pierre-Emmanuel Rautou; Valérie Paradis; Dominique Cazals-Hatem; Dominique Valla; Valérie Vilgrain; Maxime Ronot
Journal:  JHEP Rep       Date:  2020-03-09

9.  Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging.

Authors:  Jung-Hee Yoon; Ji-Yeon Kim
Journal:  Iran J Radiol       Date:  2014-01-30       Impact factor: 0.212

10.  Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.

Authors:  Jian-Wei Wu; Yue-Cheng Yu; Xian-Li Qu; Yan Zhang; Hong Gao
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.